CSCO vs. LLY: Cisco Systems vs. Eli Lilly Stock Comparison
How do Cisco Systems (CSCO) and Eli Lilly (LLY) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Cisco Systems (CSCO) is classified in the Information Technology sector (Technology Hardware & Equipment), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | CSCO | LLY |
|---|---|---|
| Name | Cisco Systems, Inc. | Eli Lilly and Company |
| Country/Region | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry Group | Technology Hardware & Equipment | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Communications Equipment | Pharmaceuticals |
| GICS Sub-Industry | Communications Equipment | Pharmaceuticals |
| Market Capitalization | 370.01 billion USD | 1,206.07 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | February 16, 1990 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | CSCO | LLY |
|---|---|---|
| Total Return (1Y) | 40.88% | 52.36% |
| Total Return (3Y, Annualized) | 26.81% | 34.18% |
| Total Return (5Y, Annualized) | 14.44% | 41.08% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | CSCO | LLY |
|---|---|---|
| Volatility (1Y, Annualized) | 36.83% | 35.34% |
| Beta (5Y) | 1.02 | 0.40 |
| Max Drawdown (5Y) | -36.68% | -34.48% |
| Avg. Volume (3M) | 18.52M | 2.52M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | CSCO | LLY |
|---|---|---|
| Sharpe Ratio (1Y) | 0.99 | 1.36 |
| Sortino Ratio (1Y) | 1.44 | 2.29 |
Profitability
ROE (TTM)
Both Cisco Systems (CSCO) at 27.32% and Eli Lilly (LLY) at 86.02% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.
CSCO
Technology Hardware & Equipment industry group
27.32%
- Max
- 42.47%
- CSCO
- 27.32%
- Q3
- 19.13%
- Median
- 11.00%
- Q1
- 1.63%
- Min
- -20.62%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
86.02%
- Max
- 109.18%
- LLY
- 86.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
Net Margin (TTM)
Eli Lilly (LLY) at 31.90% keeps the most of each sales dollar — above its industry’s net margin range — and Cisco Systems (CSCO) at 20.95% also retains a top-quartile share.
CSCO
Technology Hardware & Equipment industry group
20.95%
- Max
- 27.60%
- CSCO
- 20.95%
- Q3
- 11.66%
- Median
- 4.08%
- Q1
- 0.00%
- Min
- -11.02%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
31.90%
- LLY
- 31.90%
- Max
- 18.05%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
Operating Margin (TTM)
Both Cisco Systems (CSCO) at 27.72% and Eli Lilly (LLY) at 53.66% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
CSCO
Technology Hardware & Equipment industry group
27.72%
- Max
- 36.27%
- CSCO
- 27.72%
- Q3
- 18.36%
- Median
- 8.84%
- Q1
- 1.46%
- Min
- -21.39%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
53.66%
- Max
- 83.12%
- LLY
- 53.66%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
Profitability Metrics
| Metric | CSCO | LLY |
|---|---|---|
| ROE (TTM) | 27.32% | 86.02% |
| ROA (TTM) | 7.98% | 21.06% |
| Net Margin (TTM) | 20.95% | 31.90% |
| Operating Margin (TTM) | 27.72% | 53.66% |
| Gross Margin (TTM) | 64.52% | 83.63% |
Growth
Revenue Growth
Both Cisco Systems (CSCO) at 11.78% and Eli Lilly (LLY) at 44.70% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Only one side can be read here: Eli Lilly (LLY) reports EPS growth of 95.99%, ranked against its industry; Cisco Systems (CSCO) has no EPS growth figure this period.
Growth Metrics
| Metric | CSCO | LLY |
|---|---|---|
| Revenue Growth (YoY) | 11.78% | 44.70% |
| Revenue Growth (3Y CAGR) | 3.57% | 31.69% |
| EPS Growth (YoY) | -- | 95.99% |
| EPS Growth (3Y CAGR) | -- | 51.71% |
Financial Strength
Current Ratio (MRQ)
Both Cisco Systems (CSCO) at 0.93 and Eli Lilly (LLY) at 1.39 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
CSCO
Technology Hardware & Equipment industry group
0.93
- Max
- 5.34
- Q3
- 3.02
- Median
- 1.95
- Q1
- 1.32
- CSCO
- 0.93
- Min
- 0.17
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- LLY
- 1.39
- Min
- 0.10
Debt / Equity (MRQ)
Cisco Systems (CSCO) at 0.62 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.23 uses more debt funding than most peers.
CSCO
Technology Hardware & Equipment industry group
0.62
- Max
- 1.76
- Q3
- 0.78
- CSCO
- 0.62
- Median
- 0.24
- Q1
- 0.04
- Min
- 0.01
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.23
- Max
- 1.42
- LLY
- 1.23
- Q3
- 0.65
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | CSCO | LLY |
|---|---|---|
| Current Ratio (MRQ) | 0.93 | 1.39 |
| Debt / Equity (MRQ) | 0.62 | 1.23 |
| Net Debt / EBITDA | 0.82 | 0.96 |
Dividends
Dividend Yield (TTM)
Both Cisco Systems (CSCO) at 1.73% and Eli Lilly (LLY) at 0.49% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
CSCO
Technology Hardware & Equipment industry group
1.73%
- CSCO
- 1.73%
- Max
- 0.73%
- Q3
- 0.31%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.49%
- LLY
- 0.49%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both Cisco Systems (CSCO) at 49.85% and Eli Lilly (LLY) at 21.71% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
CSCO
Technology Hardware & Equipment industry group
49.85%
- CSCO
- 49.85%
- Max
- 32.27%
- Q3
- 14.48%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.71%
- LLY
- 21.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | CSCO | LLY |
|---|---|---|
| Dividend Yield (TTM) | 1.73% | 0.49% |
| Dividend Payout Ratio (TTM) | 49.85% | 21.71% |
Valuation
P/E Ratio (TTM)
Cisco Systems (CSCO) at 28.18 is near its industry’s usual P/E ratio, while Eli Lilly (LLY) at 43.95 sits in the richer quartile — LLY needs stronger growth or earnings quality to justify the premium.
CSCO
Technology Hardware & Equipment industry group
28.18
- Max
- 69.48
- Q3
- 41.02
- CSCO
- 28.18
- Median
- 26.39
- Q1
- 19.36
- Min
- 6.07
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
43.95
- Max
- 85.34
- LLY
- 43.95
- Q3
- 43.46
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
P/S Ratio (TTM)
Eli Lilly (LLY) at 13.95 is priced about in line with its industry on P/S ratio, while Cisco Systems (CSCO) at 5.84 sits in the pricier quartile — CSCO costs more per dollar of sales.
CSCO
Technology Hardware & Equipment industry group
5.84
- Max
- 11.30
- CSCO
- 5.84
- Q3
- 5.82
- Median
- 2.56
- Q1
- 1.05
- Min
- 0.00
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.95
- Max
- 58.18
- Q3
- 25.77
- LLY
- 13.95
- Median
- 7.30
- Q1
- 3.01
- Min
- 0.01
P/B Ratio (MRQ)
Both look rich against book: Cisco Systems (CSCO) at 7.36 sits in the upper P/B ratio quartile, and Eli Lilly (LLY) at 29.96 prices even higher, above its industry range.
CSCO
Technology Hardware & Equipment industry group
7.36
- Max
- 10.75
- CSCO
- 7.36
- Q3
- 5.52
- Median
- 3.17
- Q1
- 1.79
- Min
- 0.33
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
29.96
- LLY
- 29.96
- Max
- 13.53
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
Valuation Metrics
| Metric | CSCO | LLY |
|---|---|---|
| P/E Ratio (TTM) | 28.18 | 43.95 |
| P/S Ratio (TTM) | 5.84 | 13.95 |
| P/B Ratio (MRQ) | 7.36 | 29.96 |
| Free Cash Flow Yield (TTM) | 3.02% | 0.77% |